Kyowa Hakko Kirin Co Ltd (4151.T) Quote| Reuters.com
Edition:
United States

Kyowa Hakko Kirin Co Ltd (4151.T)

4151.T on Tokyo Stock Exchange

1,775JPY
2:00am EDT
Change (% chg)

¥72 (+4.23%)
Prev Close
¥1,703
Open
¥1,747
Day's High
¥1,783
Day's Low
¥1,724
Volume
2,102,300
Avg. Vol
1,433,076
52-wk High
¥2,321
52-wk Low
¥1,497

4151.T

Chart for 4151.T

About

Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of... (more)

Overall

Beta: 0.65
Market Cap(Mil.): ¥981,751.50
Shares Outstanding(Mil.): 576.48
Dividend: 12.50
Yield (%): 1.47

Financials

  4151.T Industry Sector
P/E (TTM): 28.64 33.26 34.67
EPS (TTM): 59.46 -- --
ROI: 5.22 14.89 14.11
ROE: 5.40 15.96 15.33

BRIEF-Medgenics enters collaboration with Kyowa Hakko Kirin

* Entered collaboration with Kyowa Hakko Kirin Co Ltd for development and commercialization of Kyowa Hakko's anti-light monoclonal antibody

Jun 06 2016

BRIEF-AstraZeneca to sell rights for constipation drug in Europe

* AstraZeneca enters into agreement with Prostrakan for rights to moventig in Europe

Mar 01 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : MarketLine
$50.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.